- ICH GCP
- EU Kliniske forsøgsregister
Seneste forsøg
EudraCT Number: 2004-001281-40 | Sponsor Protocol Number: 20040615 | Start Date: 2004-09-23 | ||||||
Sponsor Name: Gottfries Clinic | ||||||||
Full Title: Long-term study with the staphylococcus vaccine Staphypan in treatment of patients with fibromyalgia and chronic fatigue syndrome | ||||||||
Medical condition: Fibromyalgia M79.0 + Chronic fatigue syndrome F48.0 | ||||||||
|
||||||||
Population Age: Adults | Gender: Male, Female | |||||||
Trial protocol: SE (Ongoing) | ||||||||
Trial results: (No results available) |
EudraCT Number: 2004-000954-22 | Sponsor Protocol Number: CI-1008-100 | Start Date: 2004-09-23 | ||||||
Sponsor Name: Pfizer Global Research & Development | ||||||||
Full Title: A 1-Year Open-Label Safety Extension Study of Pregabalin (CI-1008) in Patients With Anxiety Disorders | ||||||||
Medical condition: Generalized Anxiety Disorder | ||||||||
|
||||||||
Population Age: Elderly | Gender: Male, Female | |||||||
Trial protocol: LV (Completed) | ||||||||
Trial results: View results |
EudraCT Number: 2004-001538-18 | Sponsor Protocol Number: 603-PG-PSC-74 | Start Date: 2004-09-23 | |||||||||||
Sponsor Name: LETI Pharma GmbH | |||||||||||||
Full Title: A randomised, double blinded, placebo controlled multicentre study for the efficacy and safety of Depigoid birch pollen | |||||||||||||
Medical condition: Patients have to suffer from IgE mediated allergic rhinits, rhinoconjunctivitis +/- asthma due to sensitization again birch pollen. | |||||||||||||
|
|||||||||||||
Population Age: Children, Adolescents, Under 18, Adults | Gender: Male, Female | ||||||||||||
Trial protocol: SE (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2004-000424-32 | Sponsor Protocol Number: 045 | Start Date: 2004-09-23 | ||||||
Sponsor Name: Merck Sharp & Dohme BV | ||||||||
Full Title: A Multicenter, Open, Noncomparative Study to Estimate the Safety, Tolerability, and Efficacy of Caspofungin Acetate in the Treatment of Adults with Invasive Candida Infections (Excluding Patients w... | ||||||||
Medical condition: Non-Blood Invasive Candidiasis | ||||||||
|
||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||
Trial protocol: BE (Completed) | ||||||||
Trial results: View results |
EudraCT Number: 2004-000113-18 | Sponsor Protocol Number: CLIC477D2302 | Start Date: 2004-09-23 | ||||||
Sponsor Name: Novartis Farmacéutica, S.A. | ||||||||
Full Title: A randomized, double-blind, placebo-controlled, multicenter study to evaluate the efficacy, safety and tolerability of licarbazepine 750-2500 mg/d combined with risperidone in the treatment of mani... | ||||||||
Medical condition: Bipolar I disorder, manic and mixed episodes | ||||||||
|
||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||
Trial protocol: ES (Completed) HU (Completed) FI (Prematurely Ended) | ||||||||
Trial results: View results |
EudraCT Number: 2004-001583-52 | Sponsor Protocol Number: Intu | Start Date: 2004-09-22 | ||||||
Sponsor Name: Lund University Hospital | ||||||||
Full Title: Balanced anestesia for intubation of newborn premature infants – a randomized intervention study Balanserad anestesi för intubation av nyfödda prematura barn – en randomiserad interventionsstudie | ||||||||
Medical condition: Respiratory insufficiency in prematrue infants requiring ventilatory assistance and therefore intubation. Premedication before intubation. | ||||||||
|
||||||||
Population Age: Preterm newborn infants, Newborns, Under 18 | Gender: Male, Female | |||||||
Trial protocol: SE (Completed) | ||||||||
Trial results: (No results available) |
EudraCT Number: 2005-000393-47 | Sponsor Protocol Number: SP000680 | Start Date: 2004-09-22 | |||||||||||
Sponsor Name: AZIENDA UNIVERSITARIA POLICLINICO UMBERTO I DI ROMA | |||||||||||||
Full Title: Effect of Cannabis Based Medicine Extract Sativex on brain function as assessed by fMRI and neurophysiologic evaluation in patients with Multiple Sclerosis a double blind, randomised, placebo-co... | |||||||||||||
Medical condition: Treatment of spasticity in patients with Multiple Sclerosis | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2004-002125-42 | Sponsor Protocol Number: CTH9507J | Start Date: 2004-09-22 | ||||||
Sponsor Name: AZIENDA SANITARIA OSPEDALIERA "S. GIOVANNI BATTISTA DI TORINO" | ||||||||
Full Title: EFFECT OF PROLONGED TREATMENT WITH TH9507 ON IGF-I LEVELS IN ADOLESCENTS WITH ISOLATED GH DEFICIENCY DUE TO HYPOTHALAMIC PATHOGENESIS | ||||||||
Medical condition: EVALUATION OF GROWTH HORMONE RELEASE | ||||||||
|
||||||||
Population Age: Adults | Gender: Male, Female | |||||||
Trial protocol: IT (Ongoing) | ||||||||
Trial results: (No results available) |
EudraCT Number: 2004-001967-24 | Sponsor Protocol Number: L 9259 | Start Date: 2004-09-22 | ||||||
Sponsor Name: Sanofi-Synthelabo Rt. | ||||||||
Full Title: Kiegészítő zolpidem kezelés friss antidepresszáns kezelés alatt álló disztimiás vagy depressziós betegek alvászavarának kezelésében | ||||||||
Medical condition: A depresszióban szenvedő betegek alvászavarára jellemzően megfigyelhető kóros alvásparaméterek lehetnek az elalvás nehezítettsége, töredezett, felszínes alvás gyakori felébredésekkel, az újra elalv... | ||||||||
|
||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||
Trial protocol: HU (Completed) | ||||||||
Trial results: View results |
EudraCT Number: 2004-001091-40 | Sponsor Protocol Number: 2-47-52030-722 | Start Date: 2004-09-22 | ||||||
Sponsor Name: Beaufour Ipsen Pharma | ||||||||
Full Title: A Phase III, Prospective, Multicentre, Randomised, Open, Parallel Group Comparison of Lanreotide Autogel (90 and 120mg) Administered by Deep Subcutaneous Injection Every Four Weeks, with Sandostati... | ||||||||
Medical condition: Treatment of clinical symptoms of carcinoid syndrome. | ||||||||
|
||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||
Trial protocol: FI (Completed) | ||||||||
Trial results: View results |